EXHIBIT 11.1
PARACELSUS HEALTHCARE CORPORATION
COMPUTATION OF EARNINGS PER SHARE - AS RESTATED
(In thousands, except per share data)
Three Months Ended Nine Months Ended
September 30, September 30,
----------------- -----------------
1996 1995 1996 1995
------- ------ ------ ------
Primary:
- -------
(1) Net income (loss) $(69,101) $(2,273) $(88,612) $ 1,419
====== ====== ====== ======
Shares used in this computation:
Weighted average common
shares outstanding 42,290 29,772 33,975 29,772
Shares applicable to stock
options and warrants, net
of shares assumed to be
purchased from proceeds at
average market price (a) - (a) -
------ ------ ------ ------
(2) Total shares for net income
per share computation 42,290 29,772 33,975 29,772
====== ====== ====== ======
Income (loss) per share:
Continuing operations $ (1.08) $ 0.09 $ (1.46) $ 0.14
Discontinued operations (0.45) (0.17) (1.01) (0.09)
Extraordinary loss (0.10) - (0.14) -
------ ------ ------ -----
Net Income (loss) per share
(1 divided by 2) $ (1.63) $ (0.08) $ (2.61) $ 0.05
====== ===== ====== =====
Fully Diluted:
- -------------
(3) Net income (loss) (1) $(69,101) $(2,273) $(88,612) $ 1,419
====== ===== ====== ======
Shares used in this computation:
Total primary shares (2) 42,290 29,772 33,975 29,772
Shares applicable to stock
options and warrants in addition
to those used in primary
computation due to the use of
period-end marker price when
higher than average (a) - (a) -
------ ------ ------ ------
(4) Total fully diluted shares 42,290 29,772 33,975 29,772
====== ====== ====== ======
Income (loss) per share:
Continuing operations $ (1.08) $ 0.09 $ (1.46) $ 0.14
Discontinued operations (0.45) (0.17) (1.01) (0.09)
Extraordinary loss (0.10) - (0.14) -
----- ----- ------ -----
Net Income (loss) per share
(3 divided by 4) $ (1.63) $ (0.08) $ (2.61) $ 0.05
===== ====== ====== =====
(a) The effect of options and warrants were anti-dilutive for the quarter and
nine months ended September 30, 1996.